ETLEVA BEJKO M.D. NPI 1164804431

NPI Details

Etleva Bejko, M.D. is a rheumatology internal medicine in Vista, CA with 6 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Etleva Bejko, M.D. NPI is 1164804431. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: CLVLND CLINIC LERNER COLLEGE OF MED OF CASE WSTN RSV UNIVERSITY
Graduation Year:2020

The provider's business location address is:

2023 W VISTA WAY STE H
VISTA, CA
ZIP 92083-030
Phone: (760) 724-5800

The NPI 1164804431 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS:Q5104)
• Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose (HCPCS:J7324)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection into tendon or ligament (HCPCS:20550)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)

The enumeration date for this NPI number is 6/23/2015 and was last updated on 2/7/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: